These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 16081524
1. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. Cariello NF, Romach EH, Colton HM, Ni H, Yoon L, Falls JG, Casey W, Creech D, Anderson SP, Benavides GR, Hoivik DJ, Brown R, Miller RT. Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524 [Abstract] [Full Text] [Related]
4. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes. Ammerschlaeger M, Beigel J, Klein KU, Mueller SO. Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357 [Abstract] [Full Text] [Related]
10. Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofibrate. Tharappel JC, Nalca A, Owens AB, Ghabrial L, Konz EC, Glauert HP, Spear BT. Toxicol Sci; 2003 Oct 11; 75(2):300-8. PubMed ID: 12883078 [Abstract] [Full Text] [Related]
11. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha. Kockx M, Princen HM, Kooistra T. Thromb Haemost; 1998 Dec 11; 80(6):942-8. PubMed ID: 9869165 [Abstract] [Full Text] [Related]
12. Species differences in the response of liver drug-metabolizing enzymes to (S)-4-O-tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric acid (EMD 392949) in vivo and in vitro. Richert L, Tuschl G, Viollon-Abadie C, Blanchard N, Bonet A, Heyd B, Halkic N, Wimmer E, Dolgos H, Mueller SO. Drug Metab Dispos; 2008 Apr 11; 36(4):702-14. PubMed ID: 18216275 [Abstract] [Full Text] [Related]
13. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists. Guo L, Fang H, Collins J, Fan XH, Dial S, Wong A, Mehta K, Blann E, Shi L, Tong W, Dragan YP. BMC Bioinformatics; 2006 Sep 06; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139 [Abstract] [Full Text] [Related]
14. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes. Rogue A, Renaud MP, Claude N, Guillouzo A, Spire C. Toxicol Appl Pharmacol; 2011 Jul 01; 254(1):18-31. PubMed ID: 21515302 [Abstract] [Full Text] [Related]
16. Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPARalpha. Al Kholaifi A, Amer A, Jeffery B, Gray TJ, Roberts RA, Bell DR. Toxicol Sci; 2008 Jul 01; 104(1):74-85. PubMed ID: 18375545 [Abstract] [Full Text] [Related]
17. Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats. Nishimura J, Dewa Y, Muguruma M, Kuroiwa Y, Yasuno H, Shima T, Jin M, Takahashi M, Umemura T, Mitsumori K. Toxicol Sci; 2007 May 01; 97(1):44-54. PubMed ID: 17264098 [Abstract] [Full Text] [Related]
18. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. Carcinogenesis; 2005 Jan 01; 26(1):219-27. PubMed ID: 15447978 [Abstract] [Full Text] [Related]